Uncategorized
Retatrutide Before and After: What 48 Weeks of Data Shows
Aug
Searches for retatrutide before and after results are usually looking for photographs. What actually exists, and what is far more useful, is 48 weeks of measured trial data showing exactly how much weight participants lost, how quickly, and at what amounts. This guide sets out that evidence honestly, including the parts that marketing pages leave out.
Table of Contents
What the Before and After Data Actually Shows
The definitive retatrutide before and after evidence comes from the Phase 2 obesity trial published in the New England Journal of Medicine. Over 48 weeks, participants at the highest weekly amount lost an average of 24.2 percent of their body weight. For someone starting at 110kg that is roughly 26kg, and for someone starting at 90kg roughly 22kg. The placebo group lost about 2 percent, which is the baseline effect of trial participation with regular monitoring.
That 24.2 percent figure is the largest average reduction recorded in an obesity drug trial, ahead of roughly 21 percent for tirzepatide and 15 percent for semaglutide in their own studies. It is an average, which means some participants did considerably better and others considerably worse.
The Retatrutide Before and After Timeline
| Period | Typical change | What was happening |
|---|---|---|
| Weeks 1 to 4 | 2 to 4 percent | Starting amount, appetite reduction begins |
| Weeks 4 to 12 | 6 to 10 percent | Escalation steps, most side effects reported here |
| Weeks 12 to 24 | 12 to 17 percent | Steepest phase, adaptation to the compound |
| Weeks 24 to 36 | 18 to 22 percent | Continued but slowing reduction |
| Weeks 36 to 48 | Up to 24.2 percent | Curve still descending at study end |
The most quoted detail from this retatrutide before and after curve is that it had not clearly flattened when the trial ended, which is often presented as proof that more would follow. It is not proof of anything. It is an unfinished measurement, and treating it as a promise is exactly the kind of overreach that makes this whole category untrustworthy.
Results by Weekly Amount
| Weekly amount | Mean reduction at 48 weeks |
|---|---|
| Placebo | About 2 percent |
| 1mg | About 8 percent |
| 4mg | About 17 percent |
| 8mg | About 22 percent |
| 12mg | 24.2 percent |
Most of the retatrutide before and after effect arrives by 4mg. The final step from 8mg to 12mg adds roughly two percentage points while side effect rates climb noticeably, which is why the Phase 3 programme concentrated on the middle of that range. Full schedules are in our dosage guide.
Changes Beyond the Scale
- Waist circumference fell alongside weight, indicating the loss was not simply fluid.
- Blood pressure improved on average across active groups.
- Triglycerides and lipid markers moved favourably.
- Liver fat reduced substantially in participants with elevated levels at baseline.
- Glycaemic markers improved, matching findings from the separate diabetes programme.
These were secondary endpoints, so they are supportive rather than conclusive. They are also the changes that never appear in a before and after photograph, despite mattering more to health than the number on the scale.
Why You Should Distrust Before and After Photos
Almost every retatrutide before and after image circulating online is unverifiable. Nobody can confirm what compound was used, at what amount, for how long, alongside what diet, training or other medication, or whether the two photographs are even the same person. Lighting, posture, timing and clothing change apparent body composition dramatically without any change in weight. Sites using these images are selling with them, not informing with them.
We do not publish before and after photographs, and we would treat any supplier that does as a warning sign rather than a credential. Retatrutide is unlicensed in the UK and our products are research use only, so photographic results claims would be marketing an unlicensed medicine, which our disclaimer explicitly rules out.
What Happens After Stopping
This is the biggest gap in the retatrutide before and after picture. The trial measured 48 weeks of treatment and did not follow participants through stopping. Evidence from the wider incretin class is consistent and uncomfortable: substantial weight regain typically follows discontinuation, because the compounds work while present and appetite signalling returns to baseline afterwards. Anyone presenting these results as permanent is describing something no study has demonstrated.
Setting Realistic Expectations
If you are researching this compound, the realistic summary is that trial averages are genuinely impressive, individual variation is wide, the side effect burden at top amounts is meaningful, the long term picture is unknown, and none of it is available to UK consumers anyway because retatrutide holds no authorisation from the MHRA. Our how to get guide covers the legal routes, and the side effects guide covers the cost side of these results.
Retatrutide Before and After FAQ
Why Individual Results Varied So Much
An average of 24.2 percent hides a wide spread. Some trial participants lost well over 30 percent of body weight, while others lost relatively little at the same weekly amount. The published data points to several reasons: tolerance of the escalation schedule, since anyone who stalled at a lower amount received less compound; baseline metabolic differences; and simple adherence over 48 weeks of weekly injections. Any retatrutide before and after figure quoted as though it applies to everyone is ignoring that spread.
This matters more than it sounds. When someone reads 24 percent and mentally applies it to themselves as a floor rather than an average, the gap between expectation and outcome becomes its own problem. Trial averages describe populations, not individuals.
The People Who Are Missing From the Results
Between roughly 7 and 16 percent of participants discontinued because of adverse events, rising with the weekly amount. Those people are part of the retatrutide before and after story even though they never appear in a results table, because they represent the share for whom the side effect burden outweighed the benefit. A supplier quoting the headline number while omitting the discontinuation rate is presenting half the study.
What the Trial Provided That Real Life Does Not
- Structured dietary guidance ran alongside treatment for every participant.
- Regular clinical monitoring caught problems early and adjusted escalation.
- Pharmaceutical grade material of verified strength and purity.
- Free supply removing any incentive to stretch or skip amounts.
- Accountability from scheduled study visits over 48 weeks.
None of those five come with a research pen bought online, which is another reason trial figures translate poorly outside a trial setting.
What are typical retatrutide before and after results?
In the Phase 2 trial, participants at the highest amount lost an average of 24.2 percent of body weight over 48 weeks, against about 2 percent on placebo.
How quickly do results appear?
Measurable change began within the first month, with the steepest phase between weeks 12 and 24 in trial data.
Are before and after photos online reliable?
No. They are unverifiable for compound, amount, duration and accompanying diet, and photographic conditions alter apparent results dramatically.
How does retatrutide compare with Mounjaro results?
Trial averages were 24.2 percent for retatrutide against roughly 21 percent for tirzepatide, though the studies were separate rather than head to head.
Does the weight come back after stopping?
No trial has followed retatrutide discontinuation, but across this drug class substantial regain after stopping is the consistent pattern.
Can I get these results in the UK?
Not lawfully outside a clinical trial. Retatrutide has no MHRA marketing authorisation and UK supply is research use only.
